2022 should prove a pivotal year for GlaxoSmithKline
GlaxoSmithKline (GSK) £17.96Gain to date: 36%Original entry point: Buy at £13.21 on 5 November 2020Investor sentiment towards GlaxoSmithKline (GSK) has continued to improve based upon a combination of self-help and agitation from...
05 May 2022